THE USE OF BROMOCRIPTINE IN THE GALACTORRHOEA‐AMENORRHOEA SYNDROMES: THE CANADIAN COOPERATIVE STUDY
- 1 February 1977
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 6 (s1), 91-99
- https://doi.org/10.1111/j.1365-2265.1977.tb03343.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cellsNature, 1975
- Clinical and Hormonal Response To Bromocriptin (CB-154) in the Galactorrhea SyndromesJournal of Clinical Endocrinology & Metabolism, 1974
- Prolactin secretion in sixty-five patients with galactorrheaAmerican Journal of Obstetrics and Gynecology, 1974
- PROLACTIN-SECRETING PITUITARY MICROADENOMASAmerican Journal of Roentgenology, 1974
- Functional Evaluation of Prolactin Secretion in Patients with Hypothalamic-Pituitary DisordersJCI Insight, 1973
- THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine)Journal of Clinical Endocrinology & Metabolism, 1972
- Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptineBMJ, 1972
- Inhibition of Prolactin Secretion and Successful Therapy of the Forbes-Albright Syndrome with l -Dopa*Journal of Clinical Endocrinology & Metabolism, 1972
- Results of Treatment in 108 Patients with Cushing's SyndromeNew England Journal of Medicine, 1971
- Effect of Pregnancy on the Somatotroph and the Prolactin Cell of the Human AdenohypophysisJournal of Clinical Endocrinology & Metabolism, 1969